Results 211 to 220 of about 12,689 (257)
A quasi‐periodic Dart‐Kite (QDK) metastructure with a golden‐ratio‐constrained strong–weak bond network simultaneously enhances strength, toughness, and damage tolerance. Its distributed topology enables predictable, tailorable crack paths for precise fracture control and stable mechanics, demonstrating a high‐performance, controllable architecture ...
Tianyu Gao +3 more
wiley +1 more source
A catalytic allosteric DNAzyme assay (SMART) is developed by engineering DNAzyme into a unimolecular biosensor, enabling highly sensitive and multiplex detection of small molecules and nucleic acids. SMART enables extraction‐free, one‐pot, one‐step, isothermal, and cost‐effective detection of biological markers, achieving >95% accuracy for rapid ...
Yanzhe Shen +12 more
wiley +1 more source
Triple‐Mode Ferroelectric Thin‐Film Transistor for Hybrid Electrical–Optical Reservoir Computing
A triple‐mode ferroelectric thin‐film transistor is developed by integrating Si3N4/HZO/IGZO layers to realize three independent memory modes: electric long‐term, electric short‐term, and optical short‐term. This single‐device architecture functions as both a reservoir and readout layer, achieving 92.43% MNIST accuracy. It offers a fully hardware‐based,
Hyeonho Lee +9 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Incremental cost-effectiveness ratios (ICERs): The silence of the lambda
Social Science & Medicine, 2006Despite the central role of the threshold incremental cost-effectiveness ratio (ICER), or lambda (lambda), in the methods and application of cost-effective analysis (CEA), little attention has been given to the determining the value of lambda. In this paper we consider 'what explains the silence of the lambda'?
Gafni, A, Birch, S
openaire +8 more sources
Incremental and Average Cost‐Effectiveness Ratios: Will Physicians Make a Distinction?
Risk Analysis, 2003Physicians are increasingly asked to use cost‐effectiveness information when evaluating alternative health care interventions. Little is known about how the way such information is presented can influence medical decision making. We presented physicians with hypothetical screening scenarios with multiple options, varying the type of cost‐effectiveness ...
John C, Hershey +4 more
openaire +4 more sources
Incremental cost-effectiveness ratio and incremental net-health benefit: two sides of the same coin
Expert Review of Pharmacoeconomics & Outcomes Research, 2001In recent years, an alternative framework for cost-effectiveness analyses has been growing in popularity. Instead of the incremental cost-effectiveness ratio for which statistical inference is often difficult, the incremental net-health benefit (INHB), a linear transformation of incremental costs and effectiveness, has been utilized.
B A, Craig, M A, Black
openaire +4 more sources
Biometrics, 2006
SummaryWith medical costs escalating over recent years, cost analysis is being conducted more and more to assess economic impact of new treatment options. An incremental cost‐effectiveness ratio (ICER) is a measure that assesses the additional cost for a new treatment for each additional unit of effectiveness, such as saving 1 year of life.
Wang, Hongkun, Zhao, Hongwei
openaire +5 more sources
SummaryWith medical costs escalating over recent years, cost analysis is being conducted more and more to assess economic impact of new treatment options. An incremental cost‐effectiveness ratio (ICER) is a measure that assesses the additional cost for a new treatment for each additional unit of effectiveness, such as saving 1 year of life.
Wang, Hongkun, Zhao, Hongwei
openaire +5 more sources
Cost-effectiveness analysis and incremental cost-effectiveness ratios
European Journal of Gastroenterology & Hepatology, 2004Cost-effectiveness analysis is a formal method of comparing alternative medical interventions with regard to their resource utilization (costs) and outcomes (effectiveness). The incremental cost-effectiveness ratio is an informative measure generated from such an analysis and represents the ratio of the difference in cost between two medical ...
Kiran, Bambha, W Ray, Kim
openaire +2 more sources
Cost-effectiveness, QALYs, and incremental cost-effectiveness ratios
Seminars in Spine Surgery, 2014The cost of healthcare in the United States has continued to grow at an unsustainable rate. Spine care has not been immune to these elevating costs. Given the current economic environment, policy makers and payers have started to consider a move towards a system of value-based healthcare.
Ravi R. Patel +2 more
openaire +1 more source
A Study on Confidence Intervals for Incremental Cost‐Effectiveness Ratios
Biometrical Journal, 2008AbstractIn health policy and economics studies, the incremental cost‐effectiveness ratio (ICER) has long been used to compare the economic consequences relative to the health benefits of therapies. Due to the skewed distributions of the costs and ICERs, much research has been done on how to obtain confidence intervals of ICERs, using either parametric ...
Hongkun, Wang, Hongwei, Zhao
openaire +2 more sources

